Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients with Stable Angina (ORESA Study) Halted

2024-512313-41-00 Stable Angina Pectoris 5 2025-05-19
VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial. VAST-A Halted

2025-521283-35-00 Cardiac arrest 5 2025-04-02
A prospective randomized, single-blind, multicenter phase II study comparing two methods of cardioplegia in cardiac surgery due to congenita… Halted

2024-511517-38-00 congenital heart malformation inchildren 4 2024-11-05
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinet… Halted

2024-514744-91-00 Obesity/overweight (healthy subjects) 3 2024-09-16
A Phase 3 Study of NTLA 2001 in participants with amyloidosis with cardiac muscle disease. Halted

2023-507220-23-00 Transthyretin Amyloidosis with Cardiomyopathy 5 2024-07-26
Bioequivalence Study of Empagliflozin Ended

2026-525434-33-00 Not applicable (submitted trial is a BE study in health 2 2026-04-07
A study to evaluate the safety and effectiveness of a new gene therapy (XC001) for people with coronary artery disease and reduced heart fun… Ended

2025-521325-33-00 Chronic angina and left ventricular dysfunction due to 4 2026-03-18
Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability s… Ended

2026-525256-29-00 Comparative bioavailability study under fasting conditi 3 2026-03-13
A bioequivalence study comparing Empagliflozin 25 mg film-coated tablets, VIANEX S.A., Greece versus Jardiance 25 mg film-coated tablets, Bo… Ended

2025-524910-28-00 none - healthy volunteers 2 2026-03-09
Bioequivalence clinical trial of two formulations of rosuvastatin. Ended

2026-525230-27-00 Hypercholesterolemia 2 2026-02-23
A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults Ended

2025-522574-36-00 Primary and secondary hypertension, and heart failure 2 2025-11-04
Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Te… Ended

2025-523137-25-00 Comparative bioequivalence study in healthy volunteers 2 2025-11-03
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the tre… Ended

2025-522975-27-00 Not applicable (submitted trial is a BE study in health 2 2025-09-29
Randomized, open-label, replicated single-dose, 4-period, 2-sequence crossover study to assess the comparative bioavailability of test produ… Ended

2025-523054-14-00 not applicable (submitted trial is bioavailability) 2 2025-09-15
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-522976-10-00 Not applicable (submitted trial is a BE study in health 2 2025-09-10
The bioavailability study of Dapagliflozin Ended

2025-522234-31-00 not applicable (submitted trial is a bioequivalence stu 2 2025-08-20
A Study of REGN7544 for the Treatment in Adult Patients with Sepsis-Induced Hypotension. Ended

2024-514946-35-00 Sepsis-Induced Hypotension 4 2025-06-24
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg tablets versus edoxaban 60 mg film-coated tablets, after a single oral… Ended

2025-522225-35-00 Healthy volunteers 2 2025-06-23
A study investigating the safety, absorption, and elimination of NNC0705-0001, a new compound that could potentially be used in the treatmen… Ended

2024-519478-38-00 Cardiometabolic diseases with an inflammatory component 1 2025-06-03
A first-in-human study to learn about how safe the study drug is in healthy participants Ended

2024-517512-30-00 Cardiac arrhythmia 1 2025-04-28
A clinical study of MK-1403 in healthy people (MK-1403-002) Ended

2023-507239-39-00 Atherosclerosis 3 2025-04-25
A Clinical Study to Compare the Impact of Multiple-dose Oral Administration of Macitentan, 10 mg versus 75 mg on Endothelin-1 Clearance, End… Ended

2024-517652-35-00 Pulmonary Arterial Hypertension 2 2025-04-01
A study comparing the new drug PG413 produced by Celon Pharma SA with the drug Eliquis available on the market in healthy volunteers. Ended

2024-519660-40-00 Prevention of stroke and systemic embolism in adult pat 2 2025-03-31
A Phase I, Randomised, Investigator- and Participant-blinded, Placebo-Controlled, Study to Assess the Safety, Tolerability, and Pharmacodyna… Ended

2024-519414-31-00 Cardiorenal disease 3 2025-03-28